Advanced Functional Nanomaterials in Medicine and Health Care

Dear Colleagues,

Technological innovations that cover virtually every branch of medicine and health care are necessary to provide safe, precise, and thus more efficient disease prevention and treatment, as well as improved quality of life for patients. This progress has also manifested in recent advancements in functional nanomaterials and nanotechnologies for diagnostics, therapeutics, and drug delivery systems. These advancements have potential clinical applications which show increasingly promising outcomes. However, there is still much work to be achieved in this area. In this Special Issue, we would like to highlight the growing interest in this field of advanced functional nanomaterials, which is currently becoming more and more established. Therefore, submissions covering all aspects of novel nanomaterials and nanotechnologies and their applications throughout the medicinal and healthcare field are welcome. These aspects include, i.e., novel approaches for the design and synthesis of nanomaterials and their bio-/functionalization, novel nanomedicine-based treatment strategies, including targeting ability, biocompatibility and biosafety issues, pre- and clinical applications, implementation of nanomaterials in medical and health care devices, theory and modeling of nanomaterial and nanodevices, advances in characterization techniques of nanomaterials for biomedical applications.

This Special Issue is also suited for participants of the NanoTech Poland 2024 conference, which will be held on 5–7 June 2024 in Poznań, Poland (https://nanotechpoland.amu.edu.pl/), whose contributions fall into the topical section B: Nanobiomedicine.

Dr. Dorota Katarzyna Flak
Dr. Tomasz Zalewski
Dr. Marta Joanna Woźniak-Budych
Dr. Łucja Przysiecka
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• drug and nucleic acid delivery
• imaging/contrast agent delivery
• theranostic nanoparticles
• nanovaccines
• personalised medicine
• targeted therapy
• nanobiotechnology
• nanodevice
• regenerative medicine
• biosafety/biocompatibility of nanomaterials
• stability of nanomaterials in biological fluids
• nanotoxicology
• pharmacokinetics and pharmacodynamics
• nanoinformatics and nanomodelling